Concepedia

Teresa Drudis

TD

Statistics

Publications

8

Citations

1.4K

H-Index

8

Active since

1993

Affiliations

Mario Negri Institute for Pharmacological Research(Current)

European Institute of Oncology

Institut Català d'Oncologia

Duran i Reynals Hospital

Teresa Drudis is an author at Mario Negri Institute for Pharmacological Research specializing in oncology, medicine, and angiogenesis in cancer.

Publications per year

1993–2009

8

Publications

8

The microtubule-affecting drug paclitaxel has antiangiogenic activity.

Dorina Belotti, Veronica Vergani, Teresa Drudis et al. · PubMed · 1996 · 646 citations

Medicine, Oncology, Pharmacology +13

Inhibition of Angiogenesis and Murine Hemangioma Growth by Batimastat, a Synthetic Inhibitor of Matrix Metalloproteinases

Giulia Taraboletti, Angela Garofalo, Dorina Belotti et al. · JNCI Journal of the National Cancer Institute · 1995 · 238 citations

Medicine, Oncology, Pharmacology +15

Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain

Xavier Castellsagué, Teresa Drudis, M. Paz Cañadas et al. · BMC Infectious Diseases · 2009 · 139 citations · Full text

Veterinary Medicine, Infectious Diseases, Infectious Disease Epidemiology +6

Low-Grade Adenosquamous Carcinoma of the Breast

Karen H. van Hoeven, Teresa Drudis, Milicent L. Cranor et al. · The American Journal of Surgical Pathology · 1993 · 136 citations

Medicine, Oncology, Pathology +17

BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity.

Carmen Gatto, Monica Rieppi, Patrizia Borsotti et al. · PubMed · 1999 · 108 citations

Medicine, Oncology, Pharmacology +12

1–5 of 8